Subcellular clearance and accumulation of huntington disease protein: A mini-review

Frontiers in Molecular Neuroscience

Volumn 9, Issue APR, 2016, Pages

  Zhao, Ting ^a   Hong, Yan ^a   Li, Xiao Jiang ^a,b   Li, Shi Hua ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Aggregation; Autophagy; Huntingtin; Neurodegeneration; Proteasome

Indexed keywords

HISTONE DEACETYLASE 6; PROTEASOME; UBIQUITIN;

ALZHEIMER DISEASE; AUTOPHAGY; BRAIN HOMOGENATE; DOWN REGULATION; FLUORESCENCE; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROPATHOLOGY; PARKINSON DISEASE; REVIEW; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING;

EID: 84975295233     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2016.00027     Document Type: Review

References (35)

1. Adam, V., Berardozzi, R., Byrdin, M., and Bourgeois, D. (2014). Phototransformable fluorescent proteins: future challenges. Curr. Opin. Chem. Biol. 20, 92-102. doi: 10.1016/j.cbpa.2014.05.016
2. Bence, N. F., Sampat, R. M., and Kopito, R. R. (2001). Impairment of the ubiquitinproteasome system by protein aggregation. Science 292, 1552-1555. doi: 10. 1126/science.292.5521.1552
3. Bett, J. S., Cook, C., Petrucelli, L., and Bates, G. P. (2009). The ubiquitinproteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington’s disease. PLoS One 4: e5128. doi: 10. 1371/journal.pone.0005128
4. Bhat, K. P., Yan, S., Wang, C. E., Li, S., and Li, X. J. (2014). Differential ubiquitination and degradation of huntingtin fragments modulated by ubiquitin-protein ligase E3A. Proc. Natl. Acad. Sci. U S A 111, 5706-5711. doi: 10.1073/pnas.1402215111
5. Chudakov, D. M., Lukyanov, S., and Lukyanov, K. A. (2007). Tracking intracellular protein movements using photoswitchable fluorescent proteins PS-CFP2 and Dendra2. Nat. Protoc. 2, 2024-2032. doi: 10.1038/nprot.2007.291
6. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., et al. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548. doi: 10.1016/s0092-8674(00)80513-9
7. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., et al. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993. doi: 10.1126/science.277. 5334.1990
8. Gutekunst, C. A., Li, S. H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., et al. (1999). Nuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathology. J. Neurosci. 19, 2522-2534. doi: 10.1093/hmg/8.7.1227
9. Juenemann, K., Schipper-Krom, S., Wiemhoefer, A., Kloss, A., Sanz Sanz, A., and Reits, E. A. (2013). Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes. J. Biol. Chem. 288, 27068-27084. doi: 10.1074/jbc.M113.486076
10. Li, S. H., and Li, X. J. (2004). Huntingtin-protein interactions and the pathogenesis of Huntington’s disease. Trends Genet. 20, 146-154. doi: 10.1016/j.tig.2004. 01.008
11. Li, H., Li, S. H., Yu, Z. X., Shelbourne, P. F., and Li, X. J. (2001). Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington’s disease mice. J. Neurosci. 21, 8473-8481.
12. Lin, C. H., Tallaksen-Greene, S., Chien, W. M., Cearley, J. A., Jackson, W. S., Crouse, A. B., et al. (2001). Neurological abnormalities in a knock-in mouse model of Huntington’s disease. Hum. Mol. Genet. 10, 137-144. doi: 10. 1093/hmg/10.2.137
13. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., et al. (2010). Cargo recognition failure is responsible for inefficient autophagy in Huntington’s disease. Nat. Neurosci. 13, 567-576. doi: 10.1038/nn.2528
14. Michalik, A., and Van Broeckhoven, C. (2004). Proteasome degrades soluble expanded polyglutamine completely and efficiently. Neurobiol. Dis. 16, 202-211. doi: 10.1016/j.nbd.2003.12.020
15. Munoz-Sanjuan, I., and Bates, G. P. (2011). The importance of integrating basic and clinical research toward the development of new therapies for Huntington’s disease. J. Clin. Invest. 121, 476-483. doi: 10.1172/JCI45364
16. Orr, A. L., Li, S., Wang, C. E., Li, H., Wang, J., Rong, J., et al. (2008). N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J. Neurosci. 28, 2783-2792. doi: 10.1523/JNEUROSCI.0106-08.2008
17. Pandey, U. B., Nie, Z., Batlevi, Y., McCray, B. A., Ritson, G. P., Nedelsky, N. B., et al. (2007). HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863. doi: 10. 1038/nature05853
18. Qin, Z. H., Wang, Y., Kegel, K. B., Kazantsev, A., Apostol, B. L., Thompson, L. M., et al. (2003). Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 12, 3231-3244. doi: 10.1093/hmg/ddg346
19. Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington’s disease. Nat. Genet. 36, 585-595. doi: 10.1038/ng1362
20. Reddy, P. H., and Shirendeb, U. P. (2012). Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria and selective synaptic degeneration in Huntington’s disease. Biochim. Biophys. Acta 1822, 101-110. doi: 10.1016/j.bbadis.2011.10.016
21. Reiner, A., Albin, R. L., Anderson, K. D., D’Amato, C. J., Penney, J. B., and Young, A. B. (1988). Differential loss of striatal projection neurons in Huntington’s disease. Proc. Natl. Acad. Sci. U S A 85, 5733-5737. doi: 10.1073/pnas.85.15. 5733
22. Richfield, E. K., Maguire-Zeiss, K. A., Vonkeman, H. E., and Voorn, P. (1995). Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington’s disease patients. Ann. Neurol. 38, 852-861. doi: 10. 1002/ana.410380605
23. Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., et al. (2014). Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10, 204-216. doi: 10.1038/nrneurol.2014.24
24. Sasazawa, Y., Sato, N., Umezawa, K., and Simizu, S. (2015). Conophylline protects cells in cellular models of neurodegenerative diseases by inducing mammalian target of rapamycin (mTOR)-independent autophagy. J. Biol. Chem. 290, 6168-6178. doi: 10.1074/jbc.m114.606293
25. Schilling, G., Becher, M. W., Sharp, A. H., Jinnah, H. A., Duan, K., Kotzuk, J. A., et al. (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407. doi: 10.1093/hmg/8.3.397
26. Schrader, E. K., Harstad, K. G., and Matouschek, A. (2009). Targeting proteins for degradation. Nat. Chem. Biol. 5, 815-822. doi: 10.1038/nchembio.250
27. Shirasaki, D. I., Greiner, E. R., Al-Ramahi, I., Gray, M., Boontheung, P., Geschwind, D. H., et al. (2012). Network organization of the huntingtin proteomic interactome in mammalian brain. Neuron 75, 41-57. doi: 10.1016/j. neuron.2012.05.024
28. Tan, J. M., Wong, E. S., Kirkpatrick, D. S., Pletnikova, O., Ko, H. S., Tay, S. P., et al. (2008). Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet. 17, 431-439. doi: 10.1093/hmg/ddm320
29. Tsvetkov, A. S., Arrasate, M., Barmada, S., Ando, D. M., Sharma, P., Shaby, B. A., et al. (2013). Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat. Chem. Biol. 9, 586-592. doi: 10.1038/nchembio.1308
30. Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., and Goldberg, A. L. (2004). Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14, 95-104. doi: 10.1016/s1097-2765(04)00151-0
31. Vonsattel, J. P., and DiFiglia, M. (1998). Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384. doi: 10.1097/00005072-199805000-00001
32. Wang, J., Wang, C. E., Orr, A., Tydlacka, S., Li, S. H., and Li, X. J. (2008a). Impaired ubiquitin-proteasome system activity in the synapses of Huntington’s disease mice. J. Cell Biol. 180, 1177-1189. doi: 10.1083/jcb.200709080
33. Wang, C. E., Zhou, H., McGuire, J. R., Cerullo, V., Lee, B., Li, S. H., et al. (2008b). Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin. J. Cell Biol. 181, 803-816. doi: 10.1083/jcb.200710158
34. Wheeler, V. C., White, J. K., Gutekunst, C. A., Vrbanac, V., Weaver, M., Li, X. J., et al. (2000). Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knockin mice. Hum. Mol. Genet. 9, 503-513. doi: 10.1093/hmg/9.4.503
35. Wong, Y. C., and Holzbaur, E. L. (2014). The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J. Neurosci. 34, 1293-1305. doi: 10.1523/JNEUROSCI.1870-13.2014